-
Product Insights
Transcription Activator BRG1 – Drugs In Development, 2023
Global Markets Direct’s Transcription Activator BRG1 provides in depth analysis on Transcription Activator BRG1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Transcription Activator BRG1 targeted therapeutics...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Gene Therapy To Activate 4-1BBL And To Target CD19 For B-Cell Malignancies in Burkitt Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gene Therapy To Activate 4-1BBL And To Target CD19 For B-Cell Malignancies in Burkitt Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gene...
-
Product Insights
Calcium Activated Neutral Protease – Drugs In Development, 2023
Global Markets Direct’s Calcium Activated Neutral Protease provides in depth analysis on Calcium Activated Neutral Protease targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Calcium Activated Neutral...
-
Product Insights
Plasminogen Activator Inhibitor 1 – Drugs In Development, 2023
Global Markets Direct’s Plasminogen Activator Inhibitor 1 provides in depth analysis on Plasminogen Activator Inhibitor 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Plasminogen Activator Inhibitor...
-
Product Insights
Proteinase Activated Receptor 2 – Drugs In Development, 2023
Global Markets Direct’s Proteinase Activated Receptor 2 provides in depth analysis on Proteinase Activated Receptor 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Proteinase Activated Receptor...
-
Product Insights
Tissue Type Plasminogen Activator – Drugs In Development, 2023
Global Markets Direct’s Tissue Type Plasminogen Activator provides in depth analysis on Tissue Type Plasminogen Activator targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Tissue Type Plasminogen...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Gene Therapy To Activate 4-1BBL And To Target CD19 For B-Cell Malignancies in Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gene Therapy To Activate 4-1BBL And To Target CD19 For B-Cell Malignancies in Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gene...
-
Product Insights
Mitogen Activated Protein Kinase 14 – Drugs In Development, 2023
Global Markets Direct’s Mitogen Activated Protein Kinase 14 provides in depth analysis on Mitogen Activated Protein Kinase 14 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Mitogen...
-
Product Insights
Mitogen Activated Protein Kinase 1 – Drugs In Development, 2023
Global Markets Direct’s Mitogen Activated Protein Kinase 1 provides in depth analysis on Mitogen Activated Protein Kinase 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Mitogen...
-
Product Insights
Peroxisome Proliferator Activated Receptor Delta – Drugs In Development, 2023
Global Markets Direct’s Peroxisome Proliferator Activated Receptor Delta provides in depth analysis on Peroxisome Proliferator Activated Receptor Delta targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Peroxisome...